Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study
Tae-Seok Lim, Jae-Seung Yun, Seon-Ah Cha, Ki-Ho Song, Ki-Dong Yoo, Yu-Bae Ahn, Yong-Moon Park, Seung-Hyun Ko
Korean J Intern Med. 2016;31(6):1110-1119.   Published online 2016 Oct 18     DOI: https://doi.org/10.3904/kjim.2016.030
Citations to this article as recorded by Crossref logo
Effect of Niacin on Carotid Atherosclerosis in Patients at Low-Density Lipoprotein-Cholesterol Goal but High Lipoprotein (a) Level: a 2-Year Follow-Up Study
Shinjeong Song, Chan Joo Lee, Jaewon Oh, Sungha Park, Seok-Min Kang, Sang-Hak Lee
Journal of Lipid and Atherosclerosis.2019; 8(1): 58.     CrossRef
Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis
Feng Huang
Diabetes Therapy.2018; 9(3): 1061.     CrossRef
Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus
H.-W. Zhang, X. Zhao, Y.-L. Guo, Y. Gao, C.-G. Zhu, N.-Q. Wu, J.-J. Li
Nutrition, Metabolism and Cardiovascular Diseases.2018; 28(10): 980.     CrossRef
ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels
Ji Eun Jun, Young Ju Choi, Yong-Ho Lee, Dae Jung Kim, Seok Won Park, Byung Wook Huh, Eun Jig Lee, Sun-Ha Jee, Kyu Yeon Hur, Sung Hee Choi, Kap Bum Huh
The Korean Journal of Internal Medicine.2018; 33(1): 138.     CrossRef
The mixed benefit of low lipoprotein(a) in type 2 diabetes
Michel P. Hermans, Sylvie A. Ahn, Michel F. Rousseau
Lipids in Health and Disease.2017;[Epub]     CrossRef